Abstract:Introduction Strategies for immunomodulation of xenograft rejection response whilst minimizing long-term immunosuppression need be developed. Polyclonal regulatory T cells (Treg) are suppressive of the xenoimmune responses. However, application of xenoantigen-specific Treg is required to achieve effective suppression and avoid opportunistic infection and malignancy for clinical xenotransplantation. We have previously shown that xenoantigen stimulation enhanced human Treg capacity to suppress the xenogeneic response. However, whether xenoantigen expanded Treg express specific cell surface markers which can be used for separating a particular xenoantigen-specific Treg subset for an effective Treg therapy needs be identified. In this study we investigated whether xenoantigen expanded human Treg express specific cell surface markers and their potential for selection of xenoantigen-specific Treg. Materials and Methods Human CD4+CD25+CD127- Treg isolated from healthy donor peripheral blood mononuclear cells (PBMC) were expanded for 3 or 4 cycles with anti-CD3/CD28 beads alone or combined with irradiated porcine PBMC as polyclonally (PlTreg) or xenoantigen stimulated Treg (XnTreg), respectively. Flow cytometry was performed to determine candidate cell surface markers and consequent xenoantigen-specific Treg subset was isolated XnTreg by cell sorting. After sorting, the resulting Treg subset was assessed for their suppressive capacity by mixed lymphocyte reaction (MLR) using irradiated porcine PBMC as xenogeneic stimulating cells, human PBMC as responder cells and autologous XnTreg as suppressing cells. Results After 3 and 4 cycles of expansion, although no difference was detected in expression of Treg activation markers CD39, CD45RO and CD15s on both XnTreg and PlTreg, XnTreg exhibited substantially upregulated expression of Treg memory markers HLA-DR and CD27 with a larger proportion of them being HLA-DR+CD27+. The HLA-DR+CD27+ Treg subset separated by cell sorting from XnTreg demonstrated significantly enhanced potency in suppression of proliferating xenoreactive responder cells at ratios of 1:4 through to 1:64, or 1:32 and 1:64 of Treg:responder cells when compared to HLA-DR+CD27+ cell-depleted or unsorted XnTreg, respectively. Discussion This study demonstrated that porcine xenoantigen expanded human Treg expressed elevated levels of Treg memory markers HLA-DR and CD27 which could be used for separation of xenoantigen-specific Treg subset. The effect of neutralizing HLA-DR and CD27 on HLA-DR+CD27+ Treg-mediated suppression of the xenogeneic response is being currently under investigation to facilitate their potential as specific markers for selection and enrichment of xenoantigen-specific human Treg. Conclusion Our data suggest that human HLA-DR+CD27+ memory-type Treg are xenoantigen-specific and have potential as an effective immunotherapy in xenotransplantation. Flow Cytometry Centre, WIMR. China Scholarship Council.

Natural Cd8(+)25(+) Regulatory T Cell-Secreted Exosomes Capable of Suppressing Cytotoxic T Lymphocyte-Mediated Immunity Against B16 Melanoma

CD4 + T cell-released exosomes inhibit CD8 + cytotoxic T-lymphocyte responses and antitumor immunity

Dendritic Cells Recruit T Cell Exosomes Via Exosomal LFA-1 Leading to Inhibition of CD8+ CTL Responses Through Downregulation of Peptide/MHC Class I and Fas Ligand-Mediated Cytotoxicity

Enhanced Suppression of Polyclonal CD8+25+ Regulatory T Cells Via Exosomal Arming of Antigen-Specific Peptide/mhc Complexes.

Redirecting Antigen Specificity to Nonspecific CD8+25+ Regular T Cells Through Antigen-Specific Peptide/mhc Complex Arming. (P1085)

In Vitro Xenoantigen Stimulated Human Tr1 Cells Enhanced Suppression of the Xenogeneic T Cell Response with Upregulated Expression of CD39

In vivo anti-tumor effect of tumor cell-derived exosomes combined with BCG

Novel Exosome-Targeted Cd4(+) T Cell Vaccine Counteracting Cd4(+)25(+) Regulatory T Cell-Mediated Immune Suppression and Stimulating Efficient Central Memory Cd8(+) Ctl Responses

PD-L1+ Exosomes from Bone Marrow-Derived Cells of Tumor-Bearing Mice Inhibit Antitumor Immunity

Dendritic Cell-Derived Exosomes Stimulate Stronger Cd8(+) Ctl Responses and Antitumor Immunity Than Tumor Cell-Derived Exosomes

Porcine-Stimulated Human Tr1 Cells Showed Enhanced Suppression in Xenoantigen Stimulation Response

Tumor-derived Exosomes Induce Initial Activation by Exosomal CD19 Antigen but Impair the Function of CD19-specific CAR T-cells Via TGF-β Signaling.

Human Hla-Dr+Cd27+Memory-Type Regulatory T Cells Show Potent Xenoantigen-Specific Suppression In Vitro

Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8 + CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells

Tumor Cell-Derived Exosome-Targeted Dendritic Cells Stimulate Stronger CD8+ CTL Responses and Antitumor Immunities

CD27-Expressing Xenoantigen-Expanded Human Regulatory T Cells Are Efficient in Suppressing Xenogeneic Immune Response

P17.09: CD27-Expressing Xenoantigen-Expanded Human Regulatory T Cells Are Efficient in Suppressing Xenogeneic Immune Response

Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.

Thioredoxin Induces Tregs To Generate An Immunotolerant Tumor Microenvironment In Metastatic Melanoma

Exosomal Pmhc-I Complex Targets T Cell-Based Vaccine to Directly Stimulate CTL Responses Leading to Antitumor Immunity in Transgenic FVBneuN and HLA-A2/HER2 Mice and Eradicating Trastuzumab-Resistant Tumor in Athymic Nude Mice

Exosomes Originating from MSCs Stimulated with TGF‐β and IFN‐γ Promote Treg Differentiation